Mar 1, 2007
By:
Laura Bush
Disposables are no longer a mistrusted new technology; they're seen as a potential solution to everyday problems.
|
Feb 1, 2007
By:
Laura Bush
The recent FDA decision that meat from cloned animals is safe for human consumption seems logical enough. A protein is a protein. But even if we can eat such meat, it doesn't necessarily make economic or ecological sense to do so.
|
Jan 1, 2007
By:
Laura Bush
Given the complexity involved in the causes, mechanisms, and kinetics of protein aggregation, industry leaders and academics should continue to share knowledge and experience in this area.
|
Dec 20, 2006
By:
Laura Bush
Lipoxen PLC (London, UK, www.lipoxen.co.uk) has agreed to license its "PolyXen" drug delivery technology to Baxter International Inc. (Deerfield, IL, www.baxter.com) to develop improved, longer-acting forms of Baxter's blood-clotting factors, such as Factor VIII.
|
Dec 1, 2006
By:
Laura Bush
In various races in the November elections, voters supported stem cell research. Now, will they prepared to fund it?
|
Nov 29, 2006
By:
Laura Bush
Invitrogen (San Diego, CA, www.invitrogen.com) believes that scaledown technologies can significantly improve clone selection and cell culture media development.
|
Nov 29, 2006
By:
Laura Bush
Generex Biotechnology Corporation (Toronto, Canada, www.generex.com) has received an Australian patent for its micellar system for delivering macromolecules through the buccal lining.
|
Nov 1, 2006
By:
Laura Bush
Whether it's for manufacturing drugs, characterizing cell substrates, or regulating new technology, quality systems provide a needed framework.
|
Oct 26, 2006
By:
Laura Bush
The US Food and Drug Administration says the final version of "Quality Systems Approaches to Pharmaceutical Good Manufacturing Practice (cGMP) Regulations," issued September 29, will help manufacturers maintain consistent high quality while allowing them to make technological improvements more easily.
|
|
